Abstract
Cancer is a dreadful disease, and it is considered as one of the biggest health problems for the human populations and demands an intense strategy to cure. Cancer causes around 70% death in lower- and middle-income countries. Recent studies have reported that natural bioactive compounds (obtained from medicinal plants) in combination with anticancer drugs have great potential to destroy cancerous cells while not affecting normal cells. Natural bioactive compounds are considered suitable candidates for anticancer drug development with the great success opportunity due to their excellent properties for modulating multiple cellular and molecular targets of oncogenesis directly or indirectly and have shown great progress past several decades. The chief anticancerous properties include the inhibition of tumor cell growth, the induction of apoptosis, DNA damage, the inhibition of topoisomerases I and II, and others. Nowadays, many researchers are on the way to develop potential drugs that can inhibit or delay the growth of tumor cells without any type of side effects from natural bioactive compounds. The chief plant-based bioactive compounds with potential cancer therapeutic potential include curcumin, camptothecin, diosgenin, epigallocatechin-3-gallate, homoharringtonine, piperine, podophyllotoxin, resveratrol, vinca alkaloids, etc.
This chapter provides a comprehensive report on the recent advancements and breakthrough accomplished in cancer treatments using natural bioactive compounds alone or in combination with other known therapies along with their possible mechanism of action on nuclear and cellular factors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahmad N, Cheng P, Mukhtar H (2000) Cell cycle dysregulation by green tea polyphenol. Biochem Biophys Res Commun 334:328–334. https://doi.org/10.1006/bbrc.2000.3297
Ashraf MA (2020) Phytochemicals as potential anticancer drugs: time to ponder nature's bounty. Biomed Res Int 2020:8602879. https://doi.org/10.1155/2020/8602879
Badawy AA, El-Magd MA, AlSadrah SA (2018) Therapeutic effect of camel milk and its exosomes on MCF7 cells in vitro and in vivo. Integr Cancer Ther 17(4):1235–1246. https://doi.org/10.1177/1534735418786000
Baskar R et al (2012) Cancer and radiation therapy: current advances and future directions. Int J Med Sci 9(3):193–199. https://doi.org/10.7150/ijms.3635
Block K et al (2015) A broad-spectrum integrative prevention design for cancer prevention and therapy. Semin Cancer Biol 35(Suppl):S276–S304. https://doi.org/10.1016/j.semcancer.2015.09.007
Choudhari AS et al (2020) Phytochemicals in cancer treatment: from preclinical studies to clinical practice. Front Pharmacol 10:1614. https://doi.org/10.3389/fphar.2019.01614
Cicerale S, Lucas L, Keast R (2010) Biological activities of phenolic compounds present in virgin olive oil. Int J Mol Sci 11(2):458–479. https://doi.org/10.3390/ijms11020458
De Silva SF, Alcorn J (2019) Flaxseed lignans as important dietary polyphenols for cancer prevention and treatment: chemistry, pharmacokinetics, and molecular targets. Pharmaceuticals 12(2):68. https://doi.org/10.3390/ph12020068
Demain AL, Vaishnav P (2011) Natural products for cancer chemotherapy. Microb Biotechnol 4(6):687–699. https://doi.org/10.1111/j.1751-7915.2010.00221.x
Farooq A et al (2019) Natural products against cancer: review on phytochemicals from marine sources in preventing cancer. Saudi Pharm J 27(6):767–777. https://doi.org/10.1016/j.jsps.2019.04.013
Feitelson MA et al (2016) Sustained proliferation in cancer: therapeutic targets. Semin Cancer Biol 35:25–54. https://doi.org/10.1016/j.semcancer.2015.02.006.Sustained
Harsha Raj M et al (2017) Suppression of VEGF-induced angiogenesis and tumor growth by Eugenia jambolana, Musa paradisiaca, and Coccinia indica extracts. Pharm Biol 55(1):1489–1499. https://doi.org/10.1080/13880209.2017.1307422000
Jiang T, Zhou C (2015) The past, present and future of immunotherapy against tumor. Trans Lung Cancer Res 4(3):253–264. https://doi.org/10.3978/j.issn.2218-6751.2015.01.06
Khan T et al (2019) Anticancer plants: a review of the active phytochemicals, applications in animal models, and regulatory aspects. Biomol Ther 10(1):47. https://doi.org/10.3390/biom10010047
Lichota A, Gwozdzinski K (2018) Anticancer activity of natural compounds from plant and marine environment. Int J Mol Sci 19(11):3533. https://doi.org/10.3390/ijms19113533
Luo KW et al (2014) Green tea (Camellia sinensis) extract inhibits both the metastasis and osteolytic components of mammary cancer 4T1 lesions in mice. J Nutr Biochem 25(4):395–403. https://doi.org/10.1016/j.jnutbio.2013.11.013
Madka V, Rao CV (2013) Anti-inflammatory phytochemicals for chemoprevention of colon cancer. Curr Cancer Drug Targets 13(5):542–557. https://doi.org/10.2174/15680096113139990036
Omara T, Kiprop AK, Ramkat RC, Cherutoi J, Kagoya S, Nyangena DM, Tebo TA, Nteziyaremye P, Karanja LN, Jepchirchir A, Maiyo A, Kiptui BJ, Mbabazi I, Nakiguli CK, Nakabuye BV, Koske MC (2020) Medicinal plants used in traditional management of cancer in Uganda: a review of ethnobotanical surveys phytochemistry and anticancer studies. Evid Based Complement Alternat Med 20201-26. https://doi.org/10.1155/2020/3529081
Oyeyinka BO, Afolayan AJ (2019) Comparative evaluation of the nutritive, mineral, and antinutritive composition of Musa sinensis L. (Banana) and Musa paradisiaca L. (Plantain) fruit compartments. Plan Theory 8(12):598. https://doi.org/10.3390/plants8120598
Pouchieu C, Galan P, Ducros V, Latino-Martel P, Hercberg S, Touvier M (2014) Plasma carotenoids and retinol and overall and breast cancer risk: a nested case-control study. Nutr Cancer 66(6):980–988. https://doi.org/10.1080/01635581.2014.936952
Prakash O et al (2013) Anticancer potential of plants and natural products: a review. Am J Pharm Sci 1:104–115. https://doi.org/10.12691/ajps-1-6-1
Rajesh E, Sankari LS, Malathi L, Krupaa JR (2015) Naturally occurring products in cancer therapy. J Phar Bioallied Sci 7(5):183. https://doi.org/10.4103/0975-7406.155895
Samadi AK et al (2015) A multi-targeted approach to suppress tumor-promoting inflammation. Semin Cancer Biol 35:S151–S184. https://doi.org/10.1016/j.semcancer.2015.03.006
Seca A, Pinto D (2018) Plant secondary metabolites as anticancer agents: successes in clinical trials and therapeutic application. Int J Mol Sci 19(1):263. https://doi.org/10.3390/ijms19010263
Sharifi-Rad J et al (2019) Natural products and synthetic analogs as a source of antitumor drugs. Biomol Ther 9(11):679. https://doi.org/10.3390/biom9110679
Sinha T (2018) Tumors: benign and malignant. Cancer Ther Oncol Int J 10(3):555790. https://doi.org/10.19080/CTOIJ.2018.10.555790
Sun Q, Heilmann J, König B (2015) Natural phenolic metabolites with anti-angiogenic properties - a review from the chemical point of view. Beilstein J Org Chem 11:249–264. https://doi.org/10.3762/bjoc.11.28
Theilen GH, Madewell BR, Carter SK (1987) Chemotherapy. In: Theilen GH, Madewell BR (eds) Veterinary cancer medicine. Lea & Febiger, Philadelphia, pp 157–166
Thielker J et al (2018) Contemporary management of benign and malignant parotid tumors. Front Surg 5:39. https://doi.org/10.3389/fsurg.2018.00039
Wang N et al (2012) Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer. Breast Cancer Res Treat 134:943–955. https://doi.org/10.1007/s10549-012-1977-9
Yamada T et al (1997) Dietary diosgenin attenuates subacute intestinal inflammation associated with indomethacin in rats. Am J Physiol 273:355–364
Acknowledgment
The authors extend their gratitude to the CSIR, New Delhi, for providing financial assistance in the form of CSIR-JRF to Neha Jain (File no. 09/149(0753)/2019-EMR-1).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Jain, N., Kaushik, P., Pareek, A., Pareek, H., Sharma, M.K. (2022). Plant-Based Bioactive Compounds in Cancer Therapeutics. In: Behera, K.K., Bist, R., Mohanty, S., Bhattacharya, M. (eds) Prebiotics, Probiotics and Nutraceuticals. Springer, Singapore. https://doi.org/10.1007/978-981-16-8990-1_3
Download citation
DOI: https://doi.org/10.1007/978-981-16-8990-1_3
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-8989-5
Online ISBN: 978-981-16-8990-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)